| First Author | Shin J | Year | 2012 |
| Journal | Blood | Volume | 119 |
| Issue | 14 | Pages | 3306-14 |
| PubMed ID | 22362037 | Mgi Jnum | J:183777 |
| Mgi Id | MGI:5319257 | Doi | 10.1182/blood-2011-05-353342 |
| Citation | Shin J, et al. (2012) Regulation of mast cell survival and function by tuberous sclerosis complex 1. Blood 119(14):3306-14 |
| abstractText | Mast cells play critical roles in allergic disorders and asthma. The importance of tuberous sclerosis complex 1/2-mammalian target of rapamycin (TSC1/2-mTOR) signaling in mast cells is unknown. Here, we report that TSC1 is a critical regulator for mTOR signaling in mast cells downstream of FcepsilonRI and c-Kit, and differentially controls mast cell degranulation and cytokine production. TSC1-deficiency results in impaired mast cell degranulation, but enhanced cytokine production in vitro and in vivo after FcepsilonRI engagement. Furthermore, TSC1 is critical for mast cell survival through multiple pathways of apoptosis including the down-regulation of p53, miR-34a, reactive oxygen species, and the up-regulation of Bcl-2. Together, these findings reveal that TSC1 is a critical regulator of mast cell activation and survival, suggesting the manipulation of the TSC1/2-mTOR pathway as a therapeutic strategy for mast cell-mediated diseases. |
